Julie Helft

7PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTumour immunologyComputational complexity and computabilityInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 30, 2025
Intratumoral delivery of FLT3L with CXCR3/CCR5 ligands promotes XCR1+ cDC1 infiltration and activates anti-tumor immunity.

Louise Gorline, Fillipe Luiz Rosa do Carmo, Pierre Bourdely

|Nov 30, 2023
Breast cancer remotely imposes a myeloid bias on haematopoietic stem cells by reprogramming the bone marrow niche.

Yohan Gerber-Ferder, Jason Cosgrove, Aleria Duperray-Susini

|Dec 03, 2021
In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4+ TH1 cell response.

Aurélien Sutra Del Galy, Silvia Menegatti, Jaime Fuentealba

|Apr 30, 2020
Engineered niches support the development of human dendritic cells in humanized mice.

Giorgio Anselmi, Kristine Vaivode, Charles-Antoine Dutertre

|Oct 29, 2017
Lysosome signaling controls the migration of dendritic cells.

Marine Bretou, Pablo J Sáez, Doriane Sanséau

Pageof 2